TABLE 4.
Isolate name | PT | Genotype | AMP | ST | TE | SF | FOX | FFC | NOR | K | CN | CIP | C | SXT | NA |
S. Typhimurium | |||||||||||||||
Sal-12 | 44 | – | S | S | S | S | S | S | S | S | S | S | S | S | S |
Sal-43 | 135 | – | S | S | S | R | S | S | S | S | S | S | S | S | S |
Sal-240 | 170 | – | S | S | S | S | S | S | S | S | S | S | S | S | S |
Sal-1000 | 135 | – | S | S | S | S | S | S | S | S | S | S | S | S | S |
Sal-1003 | 170 | – | S | S | S | S | S | S | S | S | S | S | S | S | S |
Sal-1013 | 9 | – | S | S | S | S | S | S | S | S | S | S | S | S | S |
Sal-1576 | 135a | – | S | S | S | R | S | S | S | S | S | S | S | S | S |
Sal-1657 | 135 | ΔgyrA | S | S | S | S | S | S | S | S | S | S | S | S | R |
Sal-1705 | 135 | – | S | S | S | S | S | S | S | S | S | S | S | S | S |
Sal-2103 | 135a | tetA | S | S | R | S | S | S | S | S | S | S | S | S | S |
Sal-2323 | 9 | – | S | S | S | S | S | S | S | S | S | S | S | S | S |
Sal-2327 | 135a | – | S | S | S | S | S | S | S | S | S | S | S | S | S |
Sal-2355 | 135 | – | S | S | S | S | S | S | S | S | S | S | S | S | S |
Sal-2413 | 108 | – | S | S | S | S | S | S | S | S | S | S | S | S | S |
S. Infantis | |||||||||||||||
Sal-567 | – | S | S | S | S | R | S | S | S | S | S | S | S | S | |
Sal-1023 | – | S | S | S | S | R | S | S | S | S | S | S | S | S | |
Sal-1457 | blaTEM–1, strAB | R | R | S | S | R | S | S | S | S | S | S | S | S | |
S. Singapore | |||||||||||||||
Sal-1234 | – | S | S | S | S | S | S | S | S | S | S | S | S | S | |
Sal-2350 | – | S | S | S | S | S | S | S | S | S | S | S | S | S | |
Control | |||||||||||||||
25922 | S | S | S | S | S | S | S | S | S | S | S | S | S |
NB: AMP, ampicillin; P, penicillin; ST, streptomycin; TE, tetracycline; SF, sulphafurazole; FOX, cefoxitin; FFC, florfenicol; NOR, norfloxacin; K, kanamycin; E; erythromycin; CN, gentamicin; CIP, ciprofloxacin; C, chloramphenicol; SXT, trimethoprim-sulfamethoxazole; NA, nalidixic acid; S, susceptible; R, resistant.